Glutamine Enhances Immunoregulation of Tumor Growth

Michael J. Fahr, Jacki Kornbluth, Sarah Blossom, Robert Schaeffer, Vicki Klimberg

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Background: It is known that tumor progression is associated with a depletion in host glutamine (Gln) stores and a depression of natural killer (NK) cell activity. After demonstrating an in vitro dependence of NK cell activity on Gln and glutathione concentration, this study evaluated the effects of oral Gln on Gln and glutathione metabolism, NK cell activity, and tumor growth in the tumor-bearing rat. Methods: Two days before tumor implantation, rats (n = 32) were randomized to receive Gln (1 g/kg/d) or an isonitrogenous amount of glycine by gavage and pair-fed food. On day 21 after tumor implantation, rats were killed, and tumors were measured and processed for glutaminase activity, glutathione content, and tumor morphometrics. Splenic lymphocytes were assayed for NK cell activity via a chromium (51Cr) release assay using YAC (NK-cell-sensitive mouse tumor cell line) target cells. Blood Gln and glutathione were measured. A second set of rats (n = 16) were treated similarly except that ketamine was given twice weekly to suppress NK cell activity. Results: During the 3-week study period, tumor growth was decreased by 40% in the Gln group. This decrease in growth was associated with a 30% increase in NK cell activity. Administration of ketamine to rats completely reversed the higher NK cell activity and decreased the tumor growth seen in the Gln-treated group. Conclusions: These data indicate that oral Gln supplementation, through support of host Gln stores and glutathione production, may decrease tumor growth by enhancing NK cell activity. (Journal of Parenteral and Enteral Nutrition 18:471-476, 1994).

Original languageEnglish (US)
Pages (from-to)471-476
Number of pages6
JournalJournal of Parenteral and Enteral Nutrition
Volume18
Issue number6
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Glutamine
Natural Killer Cells
Growth
Glutathione
Neoplasms
Ketamine
Glutaminase
Parenteral Nutrition
Enteral Nutrition
Chromium
Tumor Cell Line
Glycine
Lymphocytes
Food

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Glutamine Enhances Immunoregulation of Tumor Growth. / Fahr, Michael J.; Kornbluth, Jacki; Blossom, Sarah; Schaeffer, Robert; Klimberg, Vicki.

In: Journal of Parenteral and Enteral Nutrition, Vol. 18, No. 6, 1994, p. 471-476.

Research output: Contribution to journalArticle

Fahr, Michael J. ; Kornbluth, Jacki ; Blossom, Sarah ; Schaeffer, Robert ; Klimberg, Vicki. / Glutamine Enhances Immunoregulation of Tumor Growth. In: Journal of Parenteral and Enteral Nutrition. 1994 ; Vol. 18, No. 6. pp. 471-476.
@article{485876832bf640298387da2ceea0d560,
title = "Glutamine Enhances Immunoregulation of Tumor Growth",
abstract = "Background: It is known that tumor progression is associated with a depletion in host glutamine (Gln) stores and a depression of natural killer (NK) cell activity. After demonstrating an in vitro dependence of NK cell activity on Gln and glutathione concentration, this study evaluated the effects of oral Gln on Gln and glutathione metabolism, NK cell activity, and tumor growth in the tumor-bearing rat. Methods: Two days before tumor implantation, rats (n = 32) were randomized to receive Gln (1 g/kg/d) or an isonitrogenous amount of glycine by gavage and pair-fed food. On day 21 after tumor implantation, rats were killed, and tumors were measured and processed for glutaminase activity, glutathione content, and tumor morphometrics. Splenic lymphocytes were assayed for NK cell activity via a chromium (51Cr) release assay using YAC (NK-cell-sensitive mouse tumor cell line) target cells. Blood Gln and glutathione were measured. A second set of rats (n = 16) were treated similarly except that ketamine was given twice weekly to suppress NK cell activity. Results: During the 3-week study period, tumor growth was decreased by 40{\%} in the Gln group. This decrease in growth was associated with a 30{\%} increase in NK cell activity. Administration of ketamine to rats completely reversed the higher NK cell activity and decreased the tumor growth seen in the Gln-treated group. Conclusions: These data indicate that oral Gln supplementation, through support of host Gln stores and glutathione production, may decrease tumor growth by enhancing NK cell activity. (Journal of Parenteral and Enteral Nutrition 18:471-476, 1994).",
author = "Fahr, {Michael J.} and Jacki Kornbluth and Sarah Blossom and Robert Schaeffer and Vicki Klimberg",
year = "1994",
doi = "10.1177/0148607194018006471",
language = "English (US)",
volume = "18",
pages = "471--476",
journal = "JPEN. Journal of parenteral and enteral nutrition",
issn = "0148-6071",
publisher = "SAGE Publications Inc.",
number = "6",

}

TY - JOUR

T1 - Glutamine Enhances Immunoregulation of Tumor Growth

AU - Fahr, Michael J.

AU - Kornbluth, Jacki

AU - Blossom, Sarah

AU - Schaeffer, Robert

AU - Klimberg, Vicki

PY - 1994

Y1 - 1994

N2 - Background: It is known that tumor progression is associated with a depletion in host glutamine (Gln) stores and a depression of natural killer (NK) cell activity. After demonstrating an in vitro dependence of NK cell activity on Gln and glutathione concentration, this study evaluated the effects of oral Gln on Gln and glutathione metabolism, NK cell activity, and tumor growth in the tumor-bearing rat. Methods: Two days before tumor implantation, rats (n = 32) were randomized to receive Gln (1 g/kg/d) or an isonitrogenous amount of glycine by gavage and pair-fed food. On day 21 after tumor implantation, rats were killed, and tumors were measured and processed for glutaminase activity, glutathione content, and tumor morphometrics. Splenic lymphocytes were assayed for NK cell activity via a chromium (51Cr) release assay using YAC (NK-cell-sensitive mouse tumor cell line) target cells. Blood Gln and glutathione were measured. A second set of rats (n = 16) were treated similarly except that ketamine was given twice weekly to suppress NK cell activity. Results: During the 3-week study period, tumor growth was decreased by 40% in the Gln group. This decrease in growth was associated with a 30% increase in NK cell activity. Administration of ketamine to rats completely reversed the higher NK cell activity and decreased the tumor growth seen in the Gln-treated group. Conclusions: These data indicate that oral Gln supplementation, through support of host Gln stores and glutathione production, may decrease tumor growth by enhancing NK cell activity. (Journal of Parenteral and Enteral Nutrition 18:471-476, 1994).

AB - Background: It is known that tumor progression is associated with a depletion in host glutamine (Gln) stores and a depression of natural killer (NK) cell activity. After demonstrating an in vitro dependence of NK cell activity on Gln and glutathione concentration, this study evaluated the effects of oral Gln on Gln and glutathione metabolism, NK cell activity, and tumor growth in the tumor-bearing rat. Methods: Two days before tumor implantation, rats (n = 32) were randomized to receive Gln (1 g/kg/d) or an isonitrogenous amount of glycine by gavage and pair-fed food. On day 21 after tumor implantation, rats were killed, and tumors were measured and processed for glutaminase activity, glutathione content, and tumor morphometrics. Splenic lymphocytes were assayed for NK cell activity via a chromium (51Cr) release assay using YAC (NK-cell-sensitive mouse tumor cell line) target cells. Blood Gln and glutathione were measured. A second set of rats (n = 16) were treated similarly except that ketamine was given twice weekly to suppress NK cell activity. Results: During the 3-week study period, tumor growth was decreased by 40% in the Gln group. This decrease in growth was associated with a 30% increase in NK cell activity. Administration of ketamine to rats completely reversed the higher NK cell activity and decreased the tumor growth seen in the Gln-treated group. Conclusions: These data indicate that oral Gln supplementation, through support of host Gln stores and glutathione production, may decrease tumor growth by enhancing NK cell activity. (Journal of Parenteral and Enteral Nutrition 18:471-476, 1994).

UR - http://www.scopus.com/inward/record.url?scp=0028117062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028117062&partnerID=8YFLogxK

U2 - 10.1177/0148607194018006471

DO - 10.1177/0148607194018006471

M3 - Article

VL - 18

SP - 471

EP - 476

JO - JPEN. Journal of parenteral and enteral nutrition

JF - JPEN. Journal of parenteral and enteral nutrition

SN - 0148-6071

IS - 6

ER -